Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Jun 1;90(11):5374–5377. doi: 10.1073/pnas.90.11.5374

Breaching the conformational integrity of the catalytic triad of the serine protease plasmin: localized disruption of a side chain of His-603 strongly inhibits the amidolytic activity of human plasmin.

A M Mhashilkar 1, T Viswanatha 1, B A Chibber 1, F J Castellino 1
PMCID: PMC46719  PMID: 8506386

Abstract

Site-directed mutagenesis has been used to construct a cDNA that encodes a recombinant variant human plasminogen (hPg) containing a Pro-611-->Ile mutation (MrhPg). The mutein was expressed in recombinant baculovirus-infected Spodoptera frugiperda cells (IPLB-SF-21AE), and purified. After activation of this zymogen to its corresponding form of the serine protease plasmin (MrhPm), this latter enzyme was essentially inactive toward an amide plasmin substrate, most likely from alteration of the spatial relationships of the active-site His-603 to its partners of the catalytic triad, Asp-646 and Ser-741. Partial amidolytic activity of MrhPm was restored as a consequence of imidazole addition to the assay medium, due to an increase in the catalytic constant kcat of the enzyme. The serine protease inhibitor, diisopropylphosphofluoridate, when preincubated with MrhPm, did not inhibit restoration of its amidolytic activity with imidazole, whereas diisopropylphosphofluoridate did inhibit the amidolytic activity of MrhPm in the presence of imidazole. This result implies that His-603 directly influences the nucleophilic character of Ser-741. When imidazole as pretreated with alpha-N-tosyl-L-lysine chloromethyl ketone, the ability of this imidazole solution to restore amidolytic activity to MrhPm was eliminated, suggesting that N alpha-(p-tosyl)lysine chloromethyl ketone directs into the binding pocket a derivatized form of imidazole, which is ineffective as an His-603 substitute. These results indicate that the conformational reorientation of His-603 results in a malfunctional catalytic triad in the serine protease MrhPm, thus leading to an inactive enzyme despite the presence of all three essential amino acids of the catalytic triad. Addition of extramolecular imidazole restores a portion of the amidolytic activity of this mutant enzyme. These data also argue for an enzyme mechanism in which the active-center His-603 residue directly influences the nucleophilicity of the active-site Ser 741 residue.

Full text

PDF
5374

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brady L., Brzozowski A. M., Derewenda Z. S., Dodson E., Dodson G., Tolley S., Turkenburg J. P., Christiansen L., Huge-Jensen B., Norskov L. A serine protease triad forms the catalytic centre of a triacylglycerol lipase. Nature. 1990 Feb 22;343(6260):767–770. doi: 10.1038/343767a0. [DOI] [PubMed] [Google Scholar]
  2. Carter P., Abrahmsén L., Wells J. A. Probing the mechanism and improving the rate of substrate-assisted catalysis in subtilisin BPN'. Biochemistry. 1991 Jun 25;30(25):6142–6148. doi: 10.1021/bi00239a009. [DOI] [PubMed] [Google Scholar]
  3. Carter P., Wells J. A. Engineering enzyme specificity by "substrate-assisted catalysis". Science. 1987 Jul 24;237(4813):394–399. doi: 10.1126/science.3299704. [DOI] [PubMed] [Google Scholar]
  4. Davidson D. J., Castellino F. J. Structures of the asparagine-289-linked oligosaccharides assembled on recombinant human plasminogen expressed in a Mamestra brassicae cell line (IZD-MBO503). Biochemistry. 1991 Jul 9;30(27):6689–6696. doi: 10.1021/bi00241a008. [DOI] [PubMed] [Google Scholar]
  5. Davidson D. J., Fraser M. J., Castellino F. J. Oligosaccharide processing in the expression of human plasminogen cDNA by lepidopteran insect (Spodoptera frugiperda) cells. Biochemistry. 1990 Jun 12;29(23):5584–5590. doi: 10.1021/bi00475a024. [DOI] [PubMed] [Google Scholar]
  6. Davidson D. J., Higgins D. L., Castellino F. J. Plasminogen activator activities of equimolar complexes of streptokinase with variant recombinant plasminogens. Biochemistry. 1990 Apr 10;29(14):3585–3590. doi: 10.1021/bi00466a023. [DOI] [PubMed] [Google Scholar]
  7. Forsgren M., Råden B., Israelsson M., Larsson K., Hedén L. O. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett. 1987 Mar 23;213(2):254–260. doi: 10.1016/0014-5793(87)81501-6. [DOI] [PubMed] [Google Scholar]
  8. Henderson R. Catalytic activity of -chymotrypsin in which histidine-57 has been methylated. Biochem J. 1971 Aug;124(1):13–18. doi: 10.1042/bj1240013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McLean J. W., Tomlinson J. E., Kuang W. J., Eaton D. L., Chen E. Y., Fless G. M., Scanu A. M., Lawn R. M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987 Nov 12;330(6144):132–137. doi: 10.1038/330132a0. [DOI] [PubMed] [Google Scholar]
  10. Miyata T., Iwanaga S., Sakata Y., Aoki N., Takamatsu J., Kamiya T. Plasminogens Tochigi II and Nagoya: two additional molecular defects with Ala-600----Thr replacement found in plasmin light chain variants. J Biochem. 1984 Aug;96(2):277–287. doi: 10.1093/oxfordjournals.jbchem.a134836. [DOI] [PubMed] [Google Scholar]
  11. Robbins K. C., Summaria L., Hsieh B., Shah R. J. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. J Biol Chem. 1967 May 25;242(10):2333–2342. [PubMed] [Google Scholar]
  12. Toney M. D., Kirsch J. F. Direct Brønsted analysis of the restoration of activity to a mutant enzyme by exogenous amines. Science. 1989 Mar 17;243(4897):1485–1488. doi: 10.1126/science.2538921. [DOI] [PubMed] [Google Scholar]
  13. Warshel A., Naray-Szabo G., Sussman F., Hwang J. K. How do serine proteases really work? Biochemistry. 1989 May 2;28(9):3629–3637. doi: 10.1021/bi00435a001. [DOI] [PubMed] [Google Scholar]
  14. Whitefleet-Smith J., Rosen E., McLinden J., Ploplis V. A., Fraser M. J., Tomlinson J. E., McLean J. W., Castellino F. J. Expression of human plasminogen cDNA in a baculovirus vector-infected insect cell system. Arch Biochem Biophys. 1989 Jun;271(2):390–399. doi: 10.1016/0003-9861(89)90288-9. [DOI] [PubMed] [Google Scholar]
  15. Wiman B. Primary structure of peptides released during activation of human plasminogen by urokinase. Eur J Biochem. 1973 Nov 1;39(1):1–9. doi: 10.1111/j.1432-1033.1973.tb03096.x. [DOI] [PubMed] [Google Scholar]
  16. Wiman B. Primary structure of the B-chain of human plasmin. Eur J Biochem. 1977 Jun 1;76(1):129–137. doi: 10.1111/j.1432-1033.1977.tb11578.x. [DOI] [PubMed] [Google Scholar]
  17. Wohl R. C., Arzadon L., Summaria L., Robbins K. C. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes. J Biol Chem. 1977 Feb 25;252(4):1141–1147. [PubMed] [Google Scholar]
  18. Zhukovsky E. A., Robinson P. R., Oprian D. D. Transducin activation by rhodopsin without a covalent bond to the 11-cis-retinal chromophore. Science. 1991 Feb 1;251(4993):558–560. doi: 10.1126/science.1990431. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES